Symbol Lookup

Monday May 04, 2015 11:03 AM ET. Data delayed 15 minutes.
16.63
-0.07 (-0.39%)
Bid/Lots
16.62/2
Ask/Lots
16.65/1
Open/Prev Close
16.67/16.69
Day Range
16.62-16.76
52-Week Range
14.00-24.63
Vol/Avg Daily Vol
3.7K/86.6K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents
8:23AM ET on Thursday Apr 30, 2015 by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2015.

Trinity Biotech plc to Announce First Quarter Fiscal Year 2015 Financial Results
5:13AM ET on Thursday Apr 23, 2015 by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2015 on Thursday, April 30, 20...

Trinity Biotech Files $200 Mln Mixed Shelf -- ADSs Inch Lower
3:50PM ET on Wednesday Apr 22, 2015 by Midnight Trader
03:50 PM EDT, 04/22/2015 (MT Newswires) -- America depository shares of Trinity Biotech plc (TRIB) edged lower Wednesday after the manufacturer of medical diagnostic products disclosed it filed a $200 million mixed shelf offering. The offering i...
European ADRs Rise as Mining Stocks Rally
11:13AM ET on Tuesday Apr 14, 2015 by Midnight Trader
11:13 AM EDT, 04/14/2015 (MT Newswires) -- American depository receipts of European stocks were trading 1.0% higher at 144.70 on the Bank of New York Mellon Europe ADR Index on Tuesday. Gainers in Continental Europe were led by Alcatel-Lucent (AL...
Trinity Biotech plc Closes Offering of $115 Million of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise in Full of Option to Purchase Additional Notes
1:05PM ET on Thursday Apr 09, 2015 by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced today that Trinity Biotech Investment Limited, its wholly-owned subsidiary (the "Iss...

Company Information

Trinity Biotech plc (Trinity Biotech), is an Ireland-based company that develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The Company is a provider of raw materials to the life sciences industry and research institutes globally through the Company subsidiary, Fitzgerald Industries. Trinity Biotech markets its portfolio of over 400 products to customers in 110 countries around the world. Trinity Biotech has manufacturing facilities in Bray, Ireland, in Jamestown, New York, Carlsbad, California and Kansas City, Missouri in the United States. On July 26, 2013, it acquired Immco Diagnostics Inc.

CONTACT INFORMATION

HeadquartersIda Business Park
Bray, Co Wicklow, Ireland
DUBLIN, Ireland 18
Phone--
Fax--

EXECUTIVE OFFICERS

Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, and Vice President CardiacEric Brouwer
Executive DirectorJames Walsh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$395.9MBeta0.68
Revenue (TTM)$104.9MEPS$0.72
Shares Out.23.7MBook Value$8.52
Dividend Yield1.32%P/E23.1x
Annual Dividend Rate0.22 USDPrice/Sales (TTM)3.8
Ex-Div Date6/6/14P/Cash Flow (TTM)--
Pay Date7/1/14Operating Margin17.20%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample